An observational cohort study to evaluate the sustained virologic response (SVR) in treatment naive hepatitis C genotype 1 patients treated with ledipasvir/sofosbuvir with or without ribavirin

Trial Profile

An observational cohort study to evaluate the sustained virologic response (SVR) in treatment naive hepatitis C genotype 1 patients treated with ledipasvir/sofosbuvir with or without ribavirin

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 May 2016

At a glance

  • Drugs Ledipasvir/sofosbuvir (Primary) ; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 May 2016 New trial record
    • 26 Apr 2016 Results published in the Hepatology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top